(Q71014288)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8606869%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

title

Immunoreactive p53 protein in high-grade prostatic intraepithelial neoplasia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8606869%20AND%20SRC:MED&resulttype=core&format=json

high-grade prostatic intraepithelial neoplasia

15 October 2019

main subject

0 references

author name string

Humphrey PA

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8606869%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Swanson PE

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8606869%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

publication date

1 September 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8606869%20AND%20SRC:MED&resulttype=core&format=json

Pathology, Research and Practice

15 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8606869%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

volume

191

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8606869%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8606869%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

page(s)

881-887

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8606869%20AND%20SRC:MED&resulttype=core&format=json

Immunohistochemical determination of p53 protein nuclear accumulation in prostatic adenocarcinoma

15 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980972-6

7 January 2021

Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980972-6

7 January 2021

Prostatic intra-epithelial neoplasia and early invasion in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980972-6

7 January 2021

Architectural patterns of high-grade prostatic intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980972-6

7 January 2021

TP53 tumor suppressor gene: a model for investigating human mutagenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980972-6

7 January 2021

p53 in prostate cancer: frequent expressed transition mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980972-6

7 January 2021

Frequency and characterization of p53 mutations in primary and metastatic human prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980972-6

7 January 2021

Alterations of the P53 gene are associated with the progression of a human prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980972-6

7 January 2021

p53 gene alterations in human prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980972-6

7 January 2021

Markers of the metastatic phenotype in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980972-6

7 January 2021

Histologic grading of prostate cancer: a perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980972-6

7 January 2021

Immunohistochemical detection of p53 protein in human prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980972-6

7 January 2021

p53 mutations in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980972-6

7 January 2021

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980972-6

7 January 2021

Association of p53 immunoreactivity with high gleason tumor grade in prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980972-6

7 January 2021

The p53 tumour suppressor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980972-6

7 January 2021

Expression of p53 protein in prostate cancers of different histologic types

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980972-6

7 January 2021

Intraductal dysplasia: a premalignant lesion of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980972-6

7 January 2021

p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980972-6

7 January 2021

p53 mutations in benign prostatic hyperplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980972-6

7 January 2021

p53 protein accumulation and gene mutation in the progression of human prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980972-6

7 January 2021

Can Radical Prostatectomy Alter the Progression of Poorly Differentiated Prostate Cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980972-6

7 January 2021

Comparative analysis of p53 protein immunoreactivity in prostatic, lung and breast carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980972-6

7 January 2021

Multifactorial analysis of p53 alteration in human cancer: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980972-6

7 January 2021

p53 expression and clinical outcome in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980972-6

7 January 2021

P53 and Ki-67 immunoreactivity in human prostate cancer and benign hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980972-6

7 January 2021

Infrequent involvement of p53 gene mutations in the tumourigenesis of Japanese prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980972-6

7 January 2021

Proliferating cell nuclear antigen and p53 expression as prognostic factors in T1-2M0 prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980972-6

7 January 2021

Small Subgroup of Aggressive, Highly Proliferative Prostatic Carcinomas Defined by p53 Accumulation

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980972-6

7 January 2021

p53 oncogene mutations in human prostate cancer specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980972-6

7 January 2021

p53 gene mutations in human prostate cancers in Japan: different mutation spectra between Japan and western countries.

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980972-6

7 January 2021

10.1016/S0344-0338(11)80972-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8606869%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference